FHTX - Foghorn Therapeutics Inc.

QQQ $ 593.34 $ 0.00 (0 %)

DIA $ 456.43 $ 0.00 (0 %)

SPY $ 654.67 $ 0.00 (0 %)

TLT $ 91.48 $ 0.00 (0 %)

GLD $ 398.94 $ 0.00 (0 %)

Previous Close

$ 4.31

Open

$ 4.50

Bid

$ 3.55 x 3

Ask

$ 6.60 x 10

Day's Range

-- - --

52 Week Range

$ 2.94 - $ 9.70

Volume

222,479

Average Volume

Market Cap

243.64M

Beta (5Y Monthly)

$ 1.62

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	03-06-2025	01-01-1970	10-K
4	11-04-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-06-2024	03-31-2024	10-Q
7	03-07-2024	12-31-2023	10-K
8	11-02-2023	09-30-2023	10-Q
9	08-04-2023	06-30-2023	10-Q
10	05-08-2023	03-31-2023	10-Q
11	03-09-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-09-2022	03-31-2022	10-Q
15	03-10-2022	12-31-2021	10-K
16	11-09-2021	09-30-2021	10-Q
17	08-10-2021	06-30-2021	10-Q
18	05-11-2021	03-31-2021	10-Q
19	03-18-2021	12-31-2020	10-K
20	12-04-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Foghorn Therapeutics Unveils Significant A...
10/16/2025 11:04:52

12 Health Care Stocks Moving In Monday's A...
08/11/2025 21:06:28

Foghorn Therapeutics Q2 EPS $(0.28) Beats ...
08/05/2025 11:37:53

Foghorn Therapeutics (NASDAQ:FHTX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of ...

Flagship Pioneering Launches Terrana Biosc...
07/01/2025 10:33:23

JMP Securities Reiterates Market Outperfor...
05/15/2025 13:48:54

JMP Securities analyst Silvan Tuerkcan reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Market Outperform and maintains ...

Foghorn Therapeutics Q1 EPS $(0.30) Beats ...
05/14/2025 11:10:30

Foghorn Therapeutics (NASDAQ:FHTX) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of ...

JMP Securities Reiterates Market Outperfor...
04/30/2025 14:50:54

JMP Securities analyst Silvan Tuerkcan reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Market Outperform and maintains ...

HC Wainwright & Co. Reiterates Buy on Fogh...
04/30/2025 10:38:57

HC Wainwright & Co. analyst Andres Maldonado reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Buy and maintains $13 ...

Foghorn Therapeutics Presents New Data On ...
04/28/2025 20:06:32

FHD-909 (LY4050784) advancing in Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as th...

this-paypal-analyst-begins-coverage-on-a-bearish-note-here-are-top-5-initiations-for-wednesday

This PayPal Analyst Begins Coverage On A B...
04/23/2025 13:19:39

JMP Securities Initiates Coverage On Fogho...
04/23/2025 11:36:39

JMP Securities analyst Silvan Tuerkcan initiates coverage on Foghorn Therapeutics (NASDAQ:FHTX) with a Market Outperform rat...

why-pvh-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket

Why PVH Shares Are Trading Higher By Aroun...
04/01/2025 09:29:54

Foghorn Therapeutics Will Present New Prec...
03/25/2025 20:37:29

CAMBRIDGE, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical-stage biotechnology c...

HC Wainwright & Co. Reiterates Buy on Fogh...
03/07/2025 12:10:59

HC Wainwright & Co. analyst Andrew Fein reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Buy and maintains $13 price...

Foghorn Therapeutics FY 2024 GAAP EPS $(1....
03/06/2025 21:14:09

Foghorn Therapeutics (NASDAQ:FHTX) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of ...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
02/10/2025 21:05:43

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
02/04/2025 12:05:51

this-worthington-enterprises-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday

This Worthington Enterprises Analyst Begin...
01/30/2025 14:15:24

B. Riley Securities Initiates Coverage On ...
01/30/2025 10:58:35

B. Riley Securities analyst Kalpit Patel initiates coverage on Foghorn Therapeutics (NASDAQ:FHTX) with a Buy rating and anno...

HC Wainwright & Co. Reiterates Buy on Fogh...
12/17/2024 11:29:49

HC Wainwright & Co. analyst Andrew Fein reiterates Foghorn Therapeutics (NASDAQ:FHTX) with a Buy and lowers the price ta...